LONDON – The terms for the U.K. leaving the EU should have been agreed in October, but instead, the crunch meeting came and went. Now, with just 150 days to go, "anything could happen," and for the life sciences industry "it's getting harder, not easier" to cover all the bases in its contingency planning, said Steve Bates, CEO of the Bioindustry Association, in his monthly Brexit webinar.